… HPV vaccine in some countries. While HPV vaccine costs are similar or lower than other
new vaccines, delivery costs appear higher than the childhood vaccines. Countries with larger …

… deciding to recommend new vaccines. We conducted a literature review to document the
processes and frameworks for national decision-making on new vaccine introductions and …

… to vaccine is likely to be limited, primarily as a result of the prevalence of vaccine nationalism,
whereby countries adopt policies … Despite rapid acceleration of vaccine development …

… , and vaccine uptake continue to be debated vigorously, thwarting the timeliness of policy …
Our work is based on an assumption that the interventions to be accelerated are those with …

… we have gained insights into vaccine development acceleration and WHO EUL submission
… COVID-19 vaccine and which, we hope, may accelerate the use of the novel vaccines under …

… So, the strategy adopted for this study was to use one main source to track and collect the
vaccines under development data (WHO) together with complementary sources to capture …

… The potential exists for the global recognition of data for vaccines with the current legislative
framework, by making use of the many reliance or recognition processes that already exist …

… under the ACT Accelerator to accelerate the development and manufacturing of COVID-19 …
equitable global vaccine allocation—most notably the lack of a global regulatory framework to …

… and geographies to accelerate immunization as a key … evidence-based adult immunization
policies and programs. COVID-… WHO) has provided a policy framework on healthy aging that …

… , separate GMO approvals are needed in addition to the typical regulatory approvals. The
GMO regulatory framework is complex, with different regulations required at regional and at …